Clinical Trials on Dyslipidemia in New Zealand
Total 293 results
-
AstraZenecaCompleted
-
GlaxoSmithKlineCompletedDyslipidaemiasUnited States, Canada
-
GlaxoSmithKlineCompletedDyslipidemias | DyslipidaemiasUnited States
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
Arrowhead PharmaceuticalsActive, not recruitingMixed DyslipidemiaUnited States, Australia, Canada, New Zealand
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Poland, New Zealand, Canada, Hungary
-
NeuroBo Pharmaceuticals Inc.CompletedSevere Hypertriglyceridemia | Mixed DyslipidaemiaUnited States, Canada
-
Kowa Research Institute, Inc.CompletedMixed Dyslipidemia | Primary DyslipidemiaUnited States
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Arrowhead PharmaceuticalsActive, not recruitingDyslipidemiasUnited States, Australia, Canada, Poland, Netherlands, New Zealand, Hungary
-
New York Hospital QueensNYHQ Cardiac Health Center; Pivotal TherapeuticsUnknown
-
NovartisCompletedDyslipidemiaGermany, United States
-
Cumberland PharmaceuticalsCompletedDyslipidemias | HypercholesterolemiaUnited States
-
Medco Health Solutions, Inc.Celera GenomicsCompletedCardiovascular Diseases | DyslipidemiaUnited States
-
Bristol-Myers SquibbCompletedDyslipidemiaUnited States, Canada
-
Eli Lilly and CompanyCompleted
-
TakedaCompletedDyslipidemiaUnited States
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
AstraZenecaCompletedDyslipidemia, Hypercholesterolemia, HypertriglyceridemiaUnited States
-
SanofiCompletedObesity | DyslipidemiaUnited States
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
Bristol-Myers SquibbCompletedDyslipidemiaCanada, Australia, United States
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyDaiichi Sankyo GermanyCompleted
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
Eli Lilly and CompanyCompletedDyslipidemiasUnited States
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHypercholesterolemia | Mixed DyslipidemiaAustria, United Kingdom, Italy, Germany, Belgium
-
AstraZenecaAstraZeneca K.K.RecruitingDyslipidemiaDenmark, Hungary, Spain, United States, Japan, Czechia, Slovakia, Canada
-
Arisaph Pharmaceuticals IncUnknownHyperlipidemiaUnited States
-
AstraZenecaCompletedDyslipidemia | HypercholesterolemiaUnited States
-
AmgenCompletedDyslipidemiaUnited States, Poland, Czechia, Hungary, Russian Federation, Ukraine, Slovakia
-
AmgenCompletedDyslipidemiaUnited States, Belgium, Denmark, Finland, France, Italy, Spain, Hungary, Poland, Germany, Czechia, Turkey, United Kingdom, Malaysia, Australia, Hong Kong, New Zealand, Canada, South Africa, Greece, Portugal, Netherlands, Russian Federation and more
-
Hoffmann-La RocheCompleted
-
TakedaCompletedDyslipidemiaUnited States, Germany, Argentina, Mexico, Poland, South Africa, Chile, Netherlands, Peru, Estonia, Russian Federation, Czech Republic, Hungary, Lithuania, Latvia, Slovakia, United Kingdom
-
PfizerCompletedHyperlipidemiaUnited States, Spain, Taiwan, United Kingdom, Canada, Mexico, France, Hungary, Lithuania, Colombia, Romania, Russian Federation
-
AmgenCompletedDyslipidemiaUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, Czechia, Hungary, Taiwan, Colombia, Poland, Russian Federation, Switzerland, Korea, Republic of, Mexico, ... and more
-
PfizerCompletedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
Public Health Foundation of IndiaNational Heart, Lung, and Blood Institute (NHLBI); All India Institute of Medical... and other collaboratorsUnknownHypertension | Type 2 Diabetes Mellitus | DyslipidaemiaIndia, Pakistan
-
Kowa Research Institute, Inc.WithdrawnDyslipidemia | HyperlipidemiaUnited States
-
PfizerTerminatedDyslipidemia | HyperlipidemiaUnited States
-
Eli Lilly and CompanyCompleted
-
NovartisCompletedHypertension | Dyslipidemia | HypercholesterolemiaUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Kowa Research Institute, Inc.Eli Lilly and Company; Kowa Pharmaceuticals America, Inc.CompletedDyslipidemiaUnited States
-
PfizerCompletedDyslipidemiaUnited States
-
PfizerTerminatedDyslipidemia | Hypercholesterolemia | HyperlipidemiaUnited States
-
Eli Lilly and CompanyCompletedDyslipidemiaUnited States, Netherlands, Germany, Denmark, Poland, United Kingdom
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHypertension | DyslipidemiaUnited States
-
SanofiCompletedObesity | DyslipidemiaUnited States, Canada, Brazil, Australia, Italy, Sweden, Malaysia, Singapore, Taiwan, Mexico, Denmark, Korea, Republic of, Hong Kong, South Africa